The many faces and phases of borreliosis I. Lyme disease

Journal of the American Academy of Dermatology

Volumn 23, Issue 2, 1990, Pages 167-186

  Abele, Donald C ^a   Anders, Kenya H ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; BENZATHINE PENICILLIN; CEFTRIAXONE; DOXYCYCLINE; ERYTHROMYCIN; PENICILLIN G; TETRACYCLINE;

ARTHROPOD; BORRELIA; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LYME DISEASE; ORAL DRUG ADMINISTRATION; PREGNANCY; PRIORITY JOURNAL; REVIEW; SEROLOGY; TICK;

ANIMAL; BITES AND STINGS; BORRELIA BURGDORFERI GROUP; CHILD; DISEASE RESERVOIRS; DISEASE VECTORS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; LYME DISEASE; MALE; PREGNANCY; SEASONS; SEX FACTORS; SUPPORT, NON-U.S. GOV'T; TETRACYCLINES; TICKS; TIME FACTORS; UNITED STATES;

EID: 0025171070     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/0190-9622(90)70196-O     Document Type: Article

References (293)

1. Borrelia
2. Experimental infection of the hamster with Borrelia burgdorferi
3. Borrelia species (relapsing fever)
4. The spectrum of relapsing fever in the Rocky Mountains
5. Immunobiology of relapsing fever
6. Erythema migrans: a chronicle
7. Discovery of the Lyme disease spirochete: a historic review
8. Verhandlungen der dermatologischen
9. Erythema chronicum migrans
10. Erythema chronicum migrans Afzelius with meningitis
11. Spirochetes in aetiologically obscure diseases
12. Successful treatment of erythema chronicum migrans Afzelius
13. Experimentelle übertragung des erythema chronicum migrans von mensch zu mensch
14. The spirochetal etiology of erythema chronicum migrans Afzelius
15. Erythema chronicum migrans
16. Lyme arthritis: an epidemic of oligoarticular arthritis in children and adults in three Connecticut communities
17. Cases of Lyme disease in the United States: locations correlated with distribution of Ixodes dammini
18. Surveillance of Lyme disease in the United States, 1982
19. Lyme disease in Wisconsin: epidemiologic, clinical, serologic, and entomologie findings
20. Lyme disease in Minnesota: epidemiologic and serologic findings
21. Avian and mammalian hosts for spirochete-infected ticks and insects in a Lyme disease focus in Connecticut
22. Geographic distribution of humans, raccoons, and white-footed mice with antibodies to Lyme disease spirochetes in Connecticut
23. Clinical and geographic characteristics of Lyme disease in New York
24. The geographic distribution of Lyme disease in the United States
25. Lyme borreliosis in California
26. Lyme disease in Texas
27. Lyme disease in Rhode Island
28. The global distribution of Lyme disease
29. From New England to old England: the progress of Lyme disease
30. Lyme disease in Japan and its possible incriminated vector, Ixodespersulcatus [Letter]
31. Lyme borreliosis in the Soviet Union: a cooperative US-USSR report
32. Clinical manifestations of tick-borne erythema in the USSR
33. Clinical manifestations and epidemiologic characteristics of Lyme disease in Hailin County, Heilongjiang Province, China
34. Does Lyme borreliosis also occur in tropical and subtropical areas?
35. Erythema chronicum migrans and Lyme arthritis: epidemiologic evidencefor a tick vector
36. Erythema chronicum migrans and Lyme arthritis: field study of ticks
37. Lyme disease—a tick-borne spirochetosis?
38. Isolation of a cultivable spirochete from Ixodes ricinus ticks of Switzerland
39. The spirochetal etiology of Lyme disease
40. Spirochetes isolated from the blood of two patients with Lyme disease
41. DNA characterization of the spirochete that causes Lyme disease
42. DNA characterization of Lyme disease spirochetes
43. Discovery of the Lyme disease spirochete and its relation to tick vectors
44. A short amino acid sequence is shared by surface antigens of Borrelia duttonii, Borrelia hermsii, and Borrelia burgdorferi
45. Lyme disease: epidemiology, etiology, clinical spectrum, diagnosis, and treatment
46. A single recombinant plasmid expressing two major outer surface proteins of the Lyme disease spirochete
47. Characterization of a circular plasmid from Borrelia burgdorferi, etiologic agent of Lyme disease
48. Changes in infec-tivity and plasmid profile of the Lyme disease spirochete Borrelia burgdorferi as a result of in vitro cultivation
49. Genetic analysis of Borrelia
50. Antigenic variability of Borrelia burgdorferi
51. Amblyomma americanum: a potential vector of Lyme disease in New Jersey
52. Piesman J, Sinsky RJ. Ability of Ixodes scapularis, Der-macentor variabilis, and Amblyomma americanum (Acari: Ixodidae) to acquire, maintain, and transmit Lyme disease spirochetes (Borrelia burgdorferi)
53. Vector competence of ticks in the southeastern United States for Borrelia burgdorferi
54. Ticks parasitizing humans in a Lyme disease endemic area of southern New York State
55. A survey of tick bites acquired in a Lyme disease endemic area in southern New York state
56. The etiologic agent of Lyme disease in deer flies, horse flies, and mosquitos
57. Lyme disease in Canada with possible transmission by an insect
58. Lyme disease: its transmission and diagnostic features
59. Development of Borrelia burgdorferi in Ixodid tick vectors
60. Dissemination and salivary delivery of Lyme disease spirochetes in vector ticks (Acari: Ixodae)
61. Duration of tick attachment and Borrelia burgdorferi transmission
62. Potential for exposure to tick bites in recreational parks in a Lyme disease endemic area
63. Prevalence of Ixocdes dammini near the homes of Lyme disease patients in Westchester County, New York
64. Prospects for suppressing transmission of Lyme disease
65. The western black-legged tick, Ixodes pacificus: a vector of Borrelia burgdorferi
66. Infectiousness for humans of Ixodes ricinus containing Borrelia burgdorferi
67. Antibodies against Borrelia burgdorferi in Bavarian forest workers
68. Borrelia burgdorferi infections in Bavarian forest workers
69. Occupational risk of Lyme disease in endemic areas of New York State
70. Lyme disease: prevalence and clinical importance of Borrelia burgdorferi specific IgG in forestry workers
71. Borrelia burgdorferi infection in UK workers at risk of tick bites [Letter]
72. Borrelia burgdorferi infection in UK workers at risk of tick bites [Letter]
73. Observations of two high-risk populations from the Swiss plateau, a region heavily infested with Ixodes ricinus/Borrelia burgdorferi complex
74. Longitudinal assessment of the clinical and epidemiological features of Lyme disease in a closed population
75. Ecology of Ixodes dammini-bome, human babesiosis and Lyme disease
76. Mammalian and avian reservoirs for Borrelia burgdorferi
77. Presence and effects of Lyme disease in a barrier island deer population
78. Rapid emergence of a focal epidemic of Lyme disease in coastal Massachusetts
79. Incompetence of deer as reservoirs of the Lyme disease spirochete
80. Incompetence of deer as reservoirs of Borrelia burgdorferi
81. Lyme disease ecology in Wisconsin: distribution and host preferences of Ixodes dammini and prevalence of antibody to Borrelia burgdorferi in small mammals
82. Vectorial capacity of North American Ixodes ticks
83. Prevalence of the Lyme disease spirochete in populations of white-tailed deer and white-footed mice
84. Greater risk of Borrelia burgdorferi infection in dogs than in people
85. Increased risk of Lyme disease for cat owners [Letter]
86. Clinical manifestations of erythema chronicum migrans Afzelius in 161 patients. A comparison with Lyme disease
87. The early clinical manifestation of Lyme disease
88. Erythema chronicum migrans and Lyme disease
89. Clinical manifestation of Lyme disease
90. Lyme disease
91. Lyme disease: the latest great imitator
92. Lyme disease
93. The emergence of Lyme disease in a changing environment in North America and central Europe
94. Clinical manifestations and descriptive epidemiology of Lyme disease in New Jersey, 1978 to 1982
95. Lyme disease. The hidden pandemic
96. Erythema chronicum migrans Afzelius and acrodermatitis chronica atrophicans
97. The spirochetal etiology of erythema chronicum migrans Afzelius
98. Clinical features of early erythema migrans disease and related disorders
99. Cutaneous manifestations in Ixodes-bomeborrelia spirochetosis
100. Early and late cutaneous manifestations in Ixodes-bomt Borreliosis (erythema migrans borreliosis, Lyme borreliosis)
101. Erythema chronicum migrans with multiple lesions
102. Septal panniculitis as a manifestation of Lyme disease
103. Lyme disease misdiagnosed as a brown recluse spider bite [Letter]
104. Lyme disease mimicking secondary syphilis
105. Generalized exanthema, acute hepatitis with porphyrinuria and eosinophilia: Another clinical feature of Lyme disease?
106. Granulomatous hepatitis associated with Lyme disease
107. Hepatitis due to recurrent Lyme disease
108. The clinical evolution of Lyme arthritis
109. Lyme disease: a neuro-ophthalmologic view
110. Clinical mani festations of borrelia infections of the nervous system
111. Clinical manifestations and diagnosis of neuroborreliosis
112. Borrelia burgdorferi infection: a neurologist's perspective
113. Borrelia burgdorferi in the nervous system: the new “great imitator”
114. Nervous system abnormalities in Lyme disease
115. Chronic neurologic manifestations of erythema migrans borreliosis
116. Neurological findings of Lyme disease
117. CNS manifestations of third stage Lyme disease
118. Involvement of Borrelia burgdorferi in cranial nerve affection
119. Neurological manifestations of Borrelia burgdorferi infections: the enlarging clinical spectrum
120. Chronic progressive neurological involvement in Borrelia burgdorferi infection
121. Progressive borrelia encephalomyelitis
122. Tick bite menin-goradiculitis: ten cases
123. Electrophysiologic findings in meningopolyneuritis of Garin-Bu-jadoux-Bannwarth
124. High-dose penicillin therapy in meningopolyneuritis Garin-Buja-doux-Bannwarth: clinical and cerebrospinal fluid data
125. Bannwarth's syndrome and the enlarged neurological spectrum of arthropod-borne borreliosis
126. Tick-borne meningopolyneuritis (Garin-Bujadoux, Bannwarth)
127. Bannwarth's syndrome (lymphocytic menin-goradiculitis) in Sweden
128. Chronic muscle weakness caused by Borrelia burgdorferi meningo-radiculitis
129. Clinical and neu-roimmunological findings in chronic Borrelia burgdorferi radiculomyelitis (Lyme disease)
130. Spirochaetes, Lyme disease, and multiple sclerosis [Letter]
131. Differentiation of progressive borrelia encephalomyelitis from multiple sclerosis
132. Concurrent neocortical borreliosis and Alzheimer's disease
133. Lyme disease: cause of a treatable peripheral neuropathy
134. Postviral fatigue and borrelial antibodies
135. Unusual manifestations of nervous system Borrelia burgdorferi infection
136. Unusual neurological manifestations of second-stage Lyme borreliosis
137. Lyme borreliosis and multiple sclerosis
138. Lyme disease and its neurologic complications
139. The triad of neurologic manifestations of Lyme disease: meningitis, cranial neuritis, and radiculoneuritis
140. Paralysis par les tiques
141. Chronische lymphozytare meningitis, entzundliche polyneuritis und rheumatismus
142. Pseudotumor cerebri syndrome associated with Lyme disease
143. Pseudotumor cerebri and Lyme disease: a new association
144. Lyme carditis: cardiac abnormalities of Lyme disease
145. Cardiac involvement in Lyme disease: manifestations and management
146. Lyme carditis: an important cause of reversible heart block
147. Unilateral blindness caused by infection with the Lyme disease spirochete, Borrelia burgdorferi
148. The expanding ophthalmologic spectrum of Lyme disease
149. Bilateral keratitis as a manifestation of Lyme disease
150. Lyme disease associated with optic neuropathy
151. Lyme disease: ocular manifestations
152. Bilateral diffuse choroiditis and exudative retinal detachments with evidence of Lyme disease
153. Optic disc edema and Lyme disease
154. Neurological findings in Lyme disease
155. Argyll Robertson pupils in lymphocytic meningoradiculitis (Bann-warth's syndrome) [Letter]
156. Erythema chronicum migrans and Lyme arthritis: The enlarging clinical spectrum
157. Pathogenesis of Lyme arthritis: Implications for rheumatic disease
158. Demonstration of Borrelia burgdorferi in a patient with chronic Lyme arthritis
159. Borrelia arthritis in Sweden
160. Joint and bone involvement in Swedish patients with Ixodes ricinus-borne bor-relia infection
161. Lyme arthritis in Germany
162. Lyme disease presenting as seronegative rheumatoid arthritis
163. Lyme disease: a unique human model for an infectious etiology of rheumatic disease
164. Lyme disease: mimicker of juvenile arthritis
165. The pathogenesis of arthritis in Lyme disease: humoral immune responses and the role of intra-articular immune complexes
166. Lyme myositis: muscle invasion by Borrelia burgdorferi
167. Lyme disease masquerading as juvenile rheumatoid arthritis
168. Diagnosing Lyme disease: the contribution of serologic testing
169. Update: Lyme disease and cases occurring during pregnancy—United States
170. Lyme disease in pregnancy
171. Human fetal borreliosis, toxemia of pregnancy, and fetal death
172. Maternal-fetal transmission of the Lyme disease spirochete, Borrelia burgdorferi
173. Stillbirth following maternal Lyme disease
174. Lyme disease during pregnancy
175. Borrelia burgdorferi in a newborn despite oral penicillin for Lyme borreliosis during pregnancy
176. Treating erythema chronicum migrans of Lyme disease
177. A cluster of arthritis in children and adults in Lyme, Connecticut [Abstract]
178. Neurologic complications of erythema-migrans disease in childhood—clinical aspects
179. The significance of controls in Lyme arthritis of children
180. Lyme borreliosis in children
181. Late stage Lyme borreliosis in children
182. In vivo and in vitro evidence of B cell hyperactivity during Lyme disease
183. IgM rheumatoid factor in Lyme disease: correlation with disease activity, total serum IgM, and IgM antibody to Borrelia burgdorferi
184. Lyme arthritis: correlation of serum IgM and cryoglobulin with activity and serum IgG with remission
185. Antigens of Borrelia burgdorferi recognized during Lyme disease: appearance of a new immunoglobulin M response and expansion of the immunoglobulin G response late in the illness
186. Lyme disease: antigens of Borrelia burgdorferi and immune responses to them
187. Specificity of human B-cell responses of immunodominant antigens of Borrelia burgdorferi
188. Immunoglobulin G subclasses specific to Borrelia burgdorferi in patients with Lyme disease
189. IgG subclasses of specific antibodies in Ixodes ricinus-borne borreliosis
190. An IgE response to spirochete antigen in patients with Lyme disease
191. Anti-Fab antibodies in Lyme disease
192. Seronegative Lyme disease: dissociation of specific T- and B-lympho-cyte responses to Borrelia burgdorferi
193. Cellular immune findings in Lyme disease
194. Erythema chronicum migrans: evidence for cellular immune reactions in the skin lesion
195. Phagocytic cell responses to in vivo and in vitro exposure to the Lyme disease spirochete
196. Interaction between Borrelia burgdorferi and polymorphonuclear leukocytes
197. A role for inter-leukin-1 in the pathogenesis of Lyme disease
198. Lyme disease spirochetes induce human and murine interleukin-1 production
199. The role of interleukin-1 in the pathogenesis of Lyme disease
200. The role of specific antibody and complement in killing of Borrelia burgdorferi by human serum
201. Serological diagnosis of Borrelia meningitis
202. B-cell response at cellular level in cerebrospinal fluid and blood in Lyme disease and controls
203. Specificity of CSF antibodies against components of Borrelia burgdorferi in patients with meningopolyneuritis Garin-Buja-doux-Bannwarth
204. Lyme disease patients' serum contains IgM antibodies to Borrelia burgdorferi that cross-react with neuronal antigens
205. IgM in the sera of patients with Lyme neurologic disease bind to cross-reacting neuronal and Borrelia burgdorferi antigens
206. Borrelia burgdorferi as a trigger for autoimmune T-cell reactions within the central nervous system
207. The spectrum of organ and systems pathology in human Lyme disease
208. The surgical pathology of human Lyme disease: an enlarging picture
209. Clinical pathologic correlations of Lyme disease by stage
210. Demonstration of spirochaetes in patients with Lyme disease with a modified silver stain
211. Erythema chronicum migrans of Lyme disease: diagnosis by monoclonal antibodies
212. Lyme disease spirochetes and ixodid tick spirochetes share a common surface antigenic determinant defined by a monoclonal antibody
213. Immunoperox-idase staining of spirochetes in Borrelial skin diseases
214. Colony formation by Lyme disease spirochetes
215. Successful cultivation of spirochetes from skin lesions of patients with erythema chronicum migrans Afzelius and acrodermatitis chronica atrophicans
216. Borrelia burgdorferi sp: nov.: etiologic agent of Lyme disease
217. Taxonomy of the Lyme disease spirochetes
218. Electron microscope characterization of cloned and uncloned strains of Borrelia burgdorferi
219. Biology of Borrelia species
220. Evaluation of sera from patients with Lyme disease in the fluorescent treponemal antibody-absorption test for syphilis
221. Cross-reactivity in serological test for Lyme disease and other spirochetal infections
222. Immunodiagnostic tests for Lyme disease
223. Serologic studies of erythema chronicum migrans Afzelius and acrodermatitis chronica atrophicans with indirect immunofluorescence and enzyme-linked immunosorbent assays
224. The antibody response in Lyme disease
225. Antibody response in Lyme disease: evaluation of diagnostic tests
226. Ticks, spirochetes, and new diagnostic tests for Lyme disease
227. Serologic testing for Lyme disease [Editorial]
228. Serodiagnosis, Early detection and persistence of antibodies to Borrelia burgdorferi in persons with Lyme disease
229. Microbiological findings in erythema (chronicum) migrans and related disorders
230. Borderline antibody response in initial stages of lymphocytic meningitis does not rule out borreliosis
231. The usefulness of immunodiagnostic tests in the diagnosis of a case of Lyme disease
232. Serology of Lyme disease
233. Immunoperoxidase slide test for detecting antibodies to Borrelia burgdorferi
234. Use of an autologous antigen in the serologic testing of patients with erythema migrans of Lyme disease
235. Serodiagnosis of early Lyme disease: analysis of IgM and IgG antibody responses by using an antibody-capture enzyme immunoassay
236. Measurement of antibodies to the Borrelia burgdorferi flagellum improves serodiagnosis in Lyme disease
237. An indirect quantitative fluorescence immunoassay for the detection of Lyme disease serum antibody
238. Evaluation of a quantitative fluorescence immunoassay (FIAX) for detection of serum antibody to Borrelia burgdorferi
239. Antibody titer determinations against Borrelia burgdorferi in blood donors and in two different groups of patients
240. Possible pitfalls of an indirect immunofluorescence assay as the sole serological test in the diagnosis of Lyme disease
241. A comparison of test procedures for the detection of antibody to Borrelia burgdorferi
242. Enzyme-linked immunosorbent assays for the detection of class-specific immunoglobulins to Borrelia burgdorferi
243. Comparison immunoblotting and indirect enzyme-linked immunosorbent assay using different antigen preparations for diagnosing early Lyme disease
244. Serologic diagnosis of Lyme disease
245. Diagnosis of Lyme disease [Editorial]
246. Ambiguous serologies in active Lyme borreliosis
247. The diagnosis of Lyme disease: rewards and perils
248. Antibody testing in Lyme disease: a comparison of results in four laboratories
249. Quality of Lyme Disease Test [Editorial]
250. Reinfection with Borrelia burgdorferi
251. Acute neuroborreliosis in a patient previously infected with Borrelia burgdorferi [Letter]
252. Anticardiolipin antibodies in Lyme disease
253. Antibodies against Borrelia burgdorferi in Bavarian forest workers
254. Treatment of the early manifestations of Lyme disease
255. A perspective on therapy of Lyme infection
256. Susceptibility of the Lyme disease spirochete to seven antimicrobial agents
257. Clinical and microbiologic findings in six patients with erythema migrans of Lyme disease
258. Remarks on the infectious disease caused by Borrelia burgdorferi
259. New chemo-therapeutic approaches in the treatment of Lyme borreliosis
260. Ceftriaxone as effective therapy in refractory Lyme disease
261. Acute and chronic illness after tick-bite Borrelia burgdorferi infections
262. Treatment of late Lyme borreliosis—randomised comparison of ceftriaxone and penicillin
263. Treatment of Lyme disease
264. Penicillin-resistant borrelia encephalitis responding to cefotaxime
265. Treatment of Lyme borreliosis with emphasis on neurological disease
266. The use of doxycy-cline in nervous system Borrelia burgdorferi infection
267. Lyme disease: a clinical perspective
268. European Lyme borreliosis
269. The spirochetal etiology of lymphadenosis benigna cutis solitaria
270. Heterogeneity of major proteins in Lyme disease borreliae: a molecular analysis of North American and European isolates
271. Immunochemical analysis of Lyme disease spirochetes
272. Spirochetal etiology of erythema chronicum migrans disease
273. Differences between Lyme disease and European arthropod-borne Borrelia infections [Letter]
274. Antigenic heterogeneity of European Borrelia burgdorferi strains isolated from patients and ticks [Letter]
275. An unusual isolate of Borrelia burgdorferi from a tick in California
276. Ultrastructure of spirochetes isolated from Ixodes ricinus and Ixodes dammini
277. Chronic Lyme arthritis: clinical and immunological differentiation from rheumatoid arthritis
278. Lyme arthritis: immunologic and immunogenetic markers [Abstract]
279. HLA-DR in meningopolyneuritis of Garin-Bujadoux-Bannwarth: contrast to Lyme disease?
280. HLA-DR in Lyme borreliosis [Letter]
281. Erythema migrans borreliosis: an HLA-associated disease?
282. Antibodies against neural tissue and DR2 antigen in patients with Bannwarth's syndrome [Abstract]
283. Lyme disease and HLA-DR antigens
284. Lyme arthritis in Europe: comparisons with reports from North America
285. Patterns of Lyme arthritis in Europe: report of 14 cases
286. Tiny tick, big worry
287. Prospects for suppressing transmission of Lyme disease
288. Vector tick populations and Lyme disease
289. Reducing transmission of Lyme disease spirochetes in a suburban setting
290. Effect of deer reduction on abundance of the deer tick (Ixodes dammini)
291. Microgeographic distribution of deer and of Ixodes dammini